Skip to main content
News Archive

PhaseBio secures $15.6M to advance pipeline – Philadelphia Business Journal

By December 4, 2017May 22nd, 2025No Comments

phasebio-logo

Investors in the Malvern biopharmaceutical company include Silicon Valley Bank.

{iframe}https://www.bizjournals.com/philadelphia/news/2017/11/30/phasebio-silicon-valley-bank-medimmune-hypertensio.html{/iframe}

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.